DOI QR코드

DOI QR Code

Metabolomics Investigation of Cutaneous T Cell Lymphoma Based on UHPLC-QTOF/MS

  • Zhou, Qing-Yuan (School of Pharmacy, Fudan University) ;
  • Wang, Yue-Lin (School of Pharmacy, Fudan University) ;
  • Li, Xia (School of Pharmacy, Fudan University) ;
  • Shen, Xiao-Yan (Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University) ;
  • Li, Ke-Jia (Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University) ;
  • Zheng, Jie (Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University) ;
  • Yu, Yun-Qiu (School of Pharmacy, Fudan University)
  • Published : 2014.07.15

Abstract

Objectives: The identification of cutaneous T cell lymphoma (CTCL) biomarkers may serve as a predictor of disease progression and treatment response. The aim of this study was to map potential biomarkers in CTCL plasma. Design and Methods: Plasma metabolic perturbations between CTCL cases and healthy individuals were investigated using metabolomics and ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS). Results: Principal component analysis (PCA) of the spectra showed clear metabolic changes between the two groups. Thirty six potential biomarkers associated with CTCL were found. Conclusions: Based on PCA, several biomarkers were determined and further identified by LC/MS/MS analysis. All of these could be potential early markers of CTCL. In addition, we established that heparin as a nticoagulant has better pre-treatment results than EDTA with the UHPLC-QTOF/MS appraoch.

Keywords

References

  1. Chuang TY, Su WP, Muller SA (1990). Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol, 23, 254-6. https://doi.org/10.1016/0190-9622(90)70208-Y
  2. Kim YH, Liu HL, Mraz-Gernhard, S et al (2003). Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol, 139, 857-66.
  3. Kunnathur MS, Chandrasekaran G (2013). Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-(TNF-a, iNOS, COX-2, IL-1$\beta$, IL-6,IFN-$\gamma$, IL-2, GM-CSF) and pro-angiogenic growth factor-VEGF. Asian Pac J Cancer P, 14, 3909-19 https://doi.org/10.7314/APJCP.2013.14.6.3909
  4. Li Ying, Yuan WR, Shen XY, Zheng J(2008). The comparison of the efficacy of skin directed therapy versus chemotherapy for CTCL. J Clin Dermatol, 37, 91-3.
  5. Regina FP, Paulus Z, Barbara B et al (2002). Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood, 99, 800-5. https://doi.org/10.1182/blood.V99.3.800
  6. Weinstock MA, Gardstein B (1999). Twenty year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health, 89, 1240-4. https://doi.org/10.2105/AJPH.89.8.1240
  7. Wu H, Xue RY, Tang ZQ et al (2010). Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem, 396, 1385-95. https://doi.org/10.1007/s00216-009-3317-4
  8. Xia YH, Li m, Fu DD et al (2013). Effects of PTTG down-regulation on proliferation and metastasis of the SCL-1 cutaneous squamous cell carcinoma cell line. Asian Pac J Cancer P, 14, 6245-48. https://doi.org/10.7314/APJCP.2013.14.11.6245
  9. Yang W, Chen YH, Xi C et al (2013). Liquid chromatography-tandem mass spectrometry-based plasma metabolomics delineate the effect of metabolites' stability on reliability of potential biomarkers. Anal Chem, 85, 2606-10. https://doi.org/10.1021/ac303576b
  10. Yin PY, Andreas P, Holger F et al (2013). Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem, 59, 5833-845.

Cited by

  1. Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and Sézary Syndrome vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5359